Mycophenolate Mofetil
If you find any inaccurate information, please let us know by providing your feedback here

This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
C23H31NO7 433.49
4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (E)-;2-Morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
CAS RN: 128794-94-5; UNII: 9242ECW6R0.
1 DEFINITION
Mycophenolate mofetil contains NLT 98.0% and NMT 102.0% of mycophenolate mofetil (C23H31NO7), calculated on the dried basis.
2 IDENTIFICATION
Change to read:
A. SPECTROSCOPIC IDENTIFICATION TESTS (197), Infrared Spectroscopy: 197K (CN 1-MAY-2020)
B. The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.
3 ASSAY
PROCEDURE
Buffer: Triethylamine and water (1:325). Adjust with phosphoric acid to a pH of 5.3.
Mobile phase: Acetonitrile and Buffer (7:13)
Standard solution: 0.4 mg/ml of USP Mycophenolate Mofetil RS in acetonitrile
Sample solution: 0.4 mg/mL of Mycophenolate Mofetil in acetonitrile
Chromatographic system
(See Chromatography (621), System Suitability.)
Mode: LC
Detector: UV 250 nm
Column: 4.6-mm x 25-cm; 5-µm packing L7
Column temperature: 45°
Flow rate: 1.5 mL/min
Injection volume: 10 µL
System suitability
Sample: Standard solution
Suitability requirements
Tailing factor: NMT 2.0
Relative standard deviation: NMT 1.0%
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of mycophenolate mofetil (C23H31NO7) in the portion of Mycophenolate Mofetil taken:
Result = (ru /rs ) × (Cs /Cu ) × 100
ru = peak response from the Sample solution
rs = peak response from the Standard solution
Cs = concentration of USP Mycophenolate Mofetil RS in the Standard solution (mg/mL)
Cu = concentration of Mycophenolate Mofetil in the Sample solution (mg/mL)
Acceptance criteria: 98.0%–102.0% on the dried basis
4 IMPURITIES
RESIDUE ON IGNITION (281): NMT 0.1%
ORGANIC IMPURITIES
Buffer and Mobile phase: Prepare as directed in the Assay.
Sample solution: 2 mg/mL of Mycophenolate Mofetil in acetonitrile
System suitability solution: 10 µg/mL each of USP Mycophenolate Mofetil Related Compound A RS and USP Mycophenolate Mofetil Related Compound B. RS in acetonitrile
Chromatographic system
(See Chromatography (621), System Suitability.)
Mode: LC
Detector: UV 250 nm
Column: 4.6-mm x 25-cm; 5-µm packing L7
Column temperature: 45°
Flow rate: 1.5 mL/min
Injection volume: 10 µL
System suitability
Sample: System suitability solution
Suitability requirements
Resolution: NLT 1.5 between mycophenolate mofetil related compound A and mycophenolate mofetil related compound B
Analysis
Sample: Sample solution
Calculate the percentage of each impurity in the portion of Mycophenolate Mofetil taken:
Result = (ru /rT ) × 100
ru = peak response for each impurity
rT = sum of all the peak responses
Acceptance criteria: See Table 1. Disregard any peak less than 0.03%.
Table 1
| Name | Relative Retention Time | Acceptance Criteria, NMT (%) |
| Mycophenolic acida | 0.33 | 0.50 |
| Mycophenolate mofetil related compound Ab | 0.45 | 0.10 |
| Mycophenolate mofetil related compound Bc | 0.49 | 0.10 |
| N-Oxide analogd | 0.60 | 0.10 |
| 1-Morpholinoethoxy analoge | 0.86 | 0.10 |
| Mycophenolate mofetil | 1.0 | - |
| Z-Mycophenolate mofetilf | 1.1 | 0.10 |
| O-Methyl analogg | 1.2 | 0.10 |
| Methyl mycophenolateh | 1.5 | 0.10 |
| Any single unspecied impurity | - | 0.10 |
| Total impurities | - | 0.70 |
a (E)-6-(1,3-Dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoic acid.
b 2-Morpholinoethyl (E)-6-(1,3-dihydro-4,6-dihydroxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate.
c (RS)-7-Hydroxy-5-methoxy-4-methyl-6-[2-(5-methyl-2-oxo-tetrahydrofuran-5-yl)ethyl]-3H-isobenzofuran-1-one.
d 2-Morpholinoethyl (E)-6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate N-oxide.
e 2-Morpholinoethyl (RS)-(E)-6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-1-(2-morpholinoethoxy)-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate.
f 2-Morpholinoethyl (Z)-6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate.
g 2-Morpholinoethyl (E)-6-(1,3-dihydro-4,6-dimethoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate.
h Methyl (E)-6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate.
5 SPECIFIC TESTS
LOSS ON DRYING (731).
Analysis: Dry a sample under vacuum at 60 for 3 h.
Acceptance criteria: NMT 0.5%
6 ADDITIONAL REQUIREMENTS
PACKAGING AND STORAGE: Preserve in tight containers, and store at room temperature.
USP REFERENCE STANDARDS (11)
USP Mycophenolate Mofetil RS
USP Mycophenolate Mofetil Related Compound A RS
2-Morpholinoethyl (E)-6-(1,3-dihydro-4,6-dihydroxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate.
C22H29NO7 419.47
USP Mycophenolate Mofetil Related Compound B RS
(RS)-7-Hydroxy-5-methoxy-4-methyl-6-[2-(5-methyl-2-oxo-tetrahydrofuran-5-yl)ethyl]-3H-isobenzofuran-1-one.
C17H20O6 320.34

